Gene Therapy
Biotechnology
New Method Identifies Genes Affecting Health In Fraction Of A Second
A new tool which makes it possible to extract information about an individual's health from genotypes in a fraction of a second, has been developed by an academic at the University of Southampton. ... Continue Reading
Personal genomes may lead to personalized vitamin supplements
As the cost of sequencing a single human genome drops rapidly, with one company predicting a price of $100 per person in five years, soon the only reason not to look at your "personal genome" will be fear of what bad news lies in your genes. ... Continue Reading
Gene therapy increases survival for end-stage head and neck cancer
A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston. Introgen Therapeutics, Inc., reported results of its phase III trial of Advexin(r), a modified adenovirus that expresses the tumor-suppressing gene p53, for end-stage head and neck cancer. ... Continue Reading
Gene therapy shown to help men with erectile dysfunction
New research has suggested that Maxi-K gene therapy could be safe and effective for men with erectile dysfunction (ED) who have not responded to other treatments. ... Continue Reading
Genetic animal models offer new insight
Latest research findings from Rhode Island Hospital could provide a springboard for the development of gene therapies to treat arrythmias. ... Continue Reading
Gene therapy used to treat tumors
Plastic surgeons in the US have discovered a new technique of reducing the volume of cancerous tumors using gene therapy, it has been revealed. ... Continue Reading
Menstrual blood may have place in regenerative medicine
Blood produced during the menstrual cycle may prove to be a useful source of stem cells for regenerative medicine, new research has revealed. ... Continue Reading
Gene Therapy For Hereditary Lung Disease Advances
An experimental gene therapy to combat alpha-1 antitrypsin deficiency, a common hereditary disorder that causes lung and liver disease, has caused no harmful effects in patients and shows signs of being effective, University of Florida researchers say. In a clinical trial, researchers evaluated the safety of using a so-called gene vector - in this case an adeno-associated virus - to deliver a corrective gene to 12 patients who are unable to produce a protein essential for health called alpha-1 antitrypsin. ... Continue Reading
Machine Learning Could Speed Up Radiation Therapy For Cancer Patients
A new computer-based technique could eliminate hours of manual adjustment associated with a popular cancer treatment. In a paper published in the February 7 issue of Physics in Medicine and Biology, researchers from Rensselaer Polytechnic Institute and Memorial Sloan-Kettering Cancer Center describe an approach that has the potential to automatically determine acceptable radiation plans in a matter of minutes, without compromising the quality of treatment. ... Continue Reading
3-D Radiation Treatment Planning Reduces Feeding-tube Use
Although current surgical techniques and multi-modality treatment regimens allow organ preservation for a growing number of patients with head and neck cancers, remaining dependent on a feeding tube after treatment is a major problem for these patients. An analysis by Fox Chase Cancer Center researchers sought to identify which treatment-related factors are more likely to avoid feeding-tube dependency. ... Continue Reading
Subscribe to the EBN
The Longevity Newsletter
EBN contains the latest news
health tips and special offers.
View the current issue
